Abbott Laboratories (ABT)

ABT (NYSE:Health Services) EQUITY
$49.29
neg -0.52
-1.00%
Today's Range: 49.25 - 50.15 | ABT Avg Daily Volume: 6,073,000
Last Update: 08/17/17 - 3:59 PM EDT
Volume: 6,500,985
YTD Performance: 29.68%
Open: $49.63
Previous Close: $49.81
52 Week Range: $37.38 - $51.13
Oustanding Shares: 1,737,443,264
Market Cap: 84,821,980,148
6-Month Chart
TheStreet Ratings Grade for ABT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 11 9 9
Moderate Buy 2 2 2 2
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.56 1.59 1.67 1.67
Latest Dividend: 0.26
Latest Dividend Yield: 2.17%
Dividend Ex-Date: 07/12/17
Price Earnings Ratio: 76.28
Price Earnings Comparisons:
ABT Sector Avg. S&P 500
76.28 67.80 36.10
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
14.01% 10.89% 18.43%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.20 -0.10 -0.02
Net Income -68.30 -0.60 -0.23
EPS -67.80 -0.40 -0.17
Earnings for ABT:
EBITDA 4.70B
Revenue 20.85B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $0.65 $0.72 $2.48 $2.79
Number of Analysts 10 5 9 10
High Estimate $0.66 $0.74 $2.50 $2.85
Low Estimate $0.64 $0.71 $2.45 $2.75
Prior Year $0.59 $0.65 $2.20 $2.48
Growth Rate (Year over Year) 10.51% 11.08% 12.63% 12.76%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Case in point: Home Depot and Lowe's.
Look to buy at the current market level.
Update
Jun 29, 2017 | 9:02 AM EDT
Abbott Laboratories stock coverage was initiated at Guggenheim with a "Buy" rating and a $58 price target.
A rotation that started as the minor chord of the rotational symphony and is now the major one.
Barring a close below $46, we are likely to see ABT remain firm and work higher.
We really want to shake out the weak hands here.
It's a wonder to me how split this market really is.
Medtronic, Abbott Labs and Becton Dickinson appear to be offering buying opportunities.
These charts are showing bullish or bearish reversals.
Their overseas business has been carrying them.

Columnist Conversations

View Chart »  View in New Window »
View Chart »  View in New Window »
we like this chart here, it appears ready to move higher. BOUGHT BZUN OCT 35 CALL AT 3.40
Large-cap, high-quality McKesson (MCK) is too cheap now, at $147.51 or so. The stock hit $243.60 more than 2.5...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.